Beit Jala Pharmaceutical Company's latest marketcap:
As of 07/19/2026, Beit Jala Pharmaceutical Company's market capitalization has reached $30.35 M. According to our data, Beit Jala Pharmaceutical Company is the 34497th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 30.35 M |
| Revenue (ttm) | 17.43 M |
| Net Income (ttm) | 3.14 M |
| Shares Out | 7 M |
| EPS (ttm) | 0.45 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 05/03/2026 |
| Earnings Date | 07/29/2026 |
Beit Jala Pharmaceutical Company's yearly market capitalization.
| Date | Market Cap(د.أ) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/19/2026 | د.أ21.49 M | $30.35 M | 0.56% | 34497 |
| 12/28/2025 | د.أ25.2 M | $35.59 M | 28.57% | n/a |
| 10/24/2024 | د.أ19.6 M | $27.61 M | 0% | n/a |
| 10/23/2023 | د.أ19.6 M | $27.62 M | -1.75% | n/a |
| 12/15/2022 | د.أ19.95 M | $28.07 M | 5.56% | n/a |
| 12/06/2021 | د.أ18.9 M | $26.66 M | n/a |
Company Profile
Beit Jala Pharmaceutical Company engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority.
It provides its products in various forms, such as tablets, capsules, powders, oral drops, solutions, suspensions, syrups, sprays, creams, gels, lotions, ampoules, and suppositories.
The company also offers medicated shampoos; and sterile products, including eye, ear, and nose drops, as well as ear and nose ointments.
In addition, it exports its products to the Middle East and North Africa region, Europe, Central Africa, and South East Asia.
The company was formerly known as Jordan Chemical Laboratory. Beit Jala Pharmaceutical Company was founded in 1933 and is headquartered in Beit Jala, the Palestinian Authority.
Frequently Asked Questions
-
What is Beit Jala Pharmaceutical Company's (PEX-BJP) current market cap?As of 07/19/2026, Beit Jala Pharmaceutical Company (including the parent company, if applicable) has an estimated market capitalization of $30.35 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Beit Jala Pharmaceutical Company (PEX-BJP) rank globally by market cap?Beit Jala Pharmaceutical Company global market capitalization ranking is approximately 34497 as of 07/19/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.